Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald N Jones

Showing results (31-40 of 662) with videos related to

Pageof 67
Sort By:
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumoniaLionel A Mandell, Ronald N Jones
Journal of Clinical Microbiology|August 9, 2003
Distribution of fsr among Enterococcus faecalis isolates from the SENTRY antimicrobial surveillance programRonald N Jones, Lalitagauri M Deshpande
Diagnostic Microbiology and Infectious Disease|December 8, 2004
MIC quality control guidelines for doxycycline when testing gram-positive control strains by the reference methodsJames E Ross, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniaeTamara R Anderegg, Ronald N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 1995
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive SpectrumRonald N. Jones, Mary S. Barrett
Diagnostic Microbiology and Infectious Disease|October 17, 2009
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)Paul R Rhomberg, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|June 13, 2006
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?Ronald N Jones, Helio S Sader
International Journal of Antimicrobial Agents|January 21, 2004
Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinoneTamara R Anderegg, Ronald N Jones
International Journal of Antimicrobial Agents|April 26, 2005
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter sppHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 10, 2005
Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panelsPaul R Rhomberg, Ronald N Jones
Pageof 67

Showing results (31-40 of 662) with videos related to

Sort By:
Pageof 67
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumoniaLionel A Mandell, Ronald N Jones
Journal of Clinical Microbiology|August 9, 2003
Distribution of fsr among Enterococcus faecalis isolates from the SENTRY antimicrobial surveillance programRonald N Jones, Lalitagauri M Deshpande
Diagnostic Microbiology and Infectious Disease|December 8, 2004
MIC quality control guidelines for doxycycline when testing gram-positive control strains by the reference methodsJames E Ross, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniaeTamara R Anderegg, Ronald N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 1995
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive SpectrumRonald N. Jones, Mary S. Barrett
Diagnostic Microbiology and Infectious Disease|October 17, 2009
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)Paul R Rhomberg, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|June 13, 2006
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?Ronald N Jones, Helio S Sader
International Journal of Antimicrobial Agents|January 21, 2004
Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinoneTamara R Anderegg, Ronald N Jones
International Journal of Antimicrobial Agents|April 26, 2005
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter sppHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 10, 2005
Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panelsPaul R Rhomberg, Ronald N Jones
Pageof 67